Relative to patients with newly diagnosed, nonmetastatic SCCA (11%), abnormally elevated CEA values occurred more frequently in patients with unresectable/incurable disease (37%) with distant lymph node metastases (42%), and with distant visceral organ involvement (35%). The gene discussed is CEACAM5; the disease is metastatic malignant neoplasm in the lymph nodes.